Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Villaverde

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Thrombosis Research|March 15, 1988
Hyperlipemia, fibrinolysis and arteriosclerosisT Padró, C A Villaverde, M Cánovas
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Histochemical study of the participation of calcium in the development of arteriosclerotic lesions]C A Villaverde, G Escolar, M C Miret
Microcirculation, Endothelium, and Lymphatics|June 1, 1988
Thrombosis and blood cells in atherosclerosis developmentC Santolaya, M R Hernández, C A Villaverde
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo]L Badimón, C A Villaverde, M Vidal, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Various aspects of the platelets-urokinase interaction]E Bastida, C A Villaverde, M T Borruel, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Hyperlipoproteinemia and inhibitors of fibrinolysis]J J Badimón, C A Villaverde, L Badimón, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Heparin and urokinase interactions in the fibrinolytic system]C A Villaverde, L Badimón, J J Badimón, et al.
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Pharmacological aspects of tienilic acid]J J Badimón, T Padró, L Badimón, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Hypolipemic profile of plafibride in a model of experimental atherosclerosisJ J Badimón, T Padró, M Cánovas, et al.
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Inhibitors of the fibrinolytic system in various animal species and the effect of time and temperature on their preservation]L Badimón, C A Villaverde, M Vidal, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis Research|March 15, 1988
Hyperlipemia, fibrinolysis and arteriosclerosisT Padró, C A Villaverde, M Cánovas
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Histochemical study of the participation of calcium in the development of arteriosclerotic lesions]C A Villaverde, G Escolar, M C Miret
Microcirculation, Endothelium, and Lymphatics|June 1, 1988
Thrombosis and blood cells in atherosclerosis developmentC Santolaya, M R Hernández, C A Villaverde
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo]L Badimón, C A Villaverde, M Vidal, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Various aspects of the platelets-urokinase interaction]E Bastida, C A Villaverde, M T Borruel, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Hyperlipoproteinemia and inhibitors of fibrinolysis]J J Badimón, C A Villaverde, L Badimón, et al.
Archivos De Farmacologia Y Toxicologia|December 1, 1979
[Heparin and urokinase interactions in the fibrinolytic system]C A Villaverde, L Badimón, J J Badimón, et al.
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Pharmacological aspects of tienilic acid]J J Badimón, T Padró, L Badimón, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Hypolipemic profile of plafibride in a model of experimental atherosclerosisJ J Badimón, T Padró, M Cánovas, et al.
Archivos De Farmacologia Y Toxicologia|April 1, 1981
[Inhibitors of the fibrinolytic system in various animal species and the effect of time and temperature on their preservation]L Badimón, C A Villaverde, M Vidal, et al.
Pageof 3